Related Experiment Video

Updated: Jun 25, 2026

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Improvement of diastolic function after regression of left ventricular hypertrophy

Raúl Teniente-Valente1, Sergio Solorio, Enrique Vargas-Salado

  • 1Cardiology Department, UMAE 1 Bajio, Mexican Institute of Social Security, Leon, Guanajuato, Mexico. dr.teniente@yahoo.com

Archivos De Cardiologia De Mexico
|February 12, 2009
PubMed

Insights

Angiotensin converting enzyme (ACE) inhibitor and diuretic treatment improved diastolic function in hypertensive patients with left ventricular hypertrophy. Blood pressure and left ventricular mass index significantly decreased, enhancing diastolic filling.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Pharmacology

Background:

  • Left ventricular hypertrophy (LVH) is a common complication of hypertension.
  • Abnormal diastolic function is a hallmark of hypertensive heart disease.
  • Regression of LVH is crucial for improving cardiac outcomes.

Purpose of the Study:

  • To assess diastolic function following LVH regression in hypertensive patients.
  • To evaluate the efficacy of ACE inhibitor and diuretic therapy in managing hypertension and LVH.
  • To determine the impact of blood pressure control on cardiac function.

Main Methods:

  • Ninety-eight hypertensive patients with LVH received captopril and chlortalidone for 12 months.
  • Blood pressure, LV mass index (echocardiography), and diastolic function (Doppler ultrasound) were monitored quarterly.
  • Treatment aimed for blood pressure <140/90 mm Hg.

Main Results:

  • Significant reductions in systolic (165 to 137 mm Hg) and diastolic (99 to 86 mm Hg) blood pressure were achieved.
  • LV mass index decreased significantly (155.4 to 121.7 g/m2).
  • Late diastolic filling (A wave) and E/A ratio improved, indicating better diastolic function.

Conclusions:

  • Captopril and chlortalidone effectively reduced blood pressure and LV mass in hypertensive patients.
  • Regression of LVH with treatment led to improvements in diastolic function indexes.
  • Achieving blood pressure control is key to reversing cardiac remodeling and improving diastolic function.
Abstract

More Related Videos

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism11:04

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism

Published on: September 1, 2014

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...